Pharmacological Effects of Genus Lonicera and its Application in Tumors of the Digestive System

Authors

  • Simeng Pi
  • Jieying Wang
  • Qifan Yang

DOI:

https://doi.org/10.54097/t6kjwz34

Keywords:

Lonicera, pharmacological effects, tumors, digestive system, immunology.

Abstract

As an ingredient of Chinese herbal medicine with a long history of use, honeysuckle is popularly loved for its fragrant odor and elegant flower shape. The biological components extracted from Lonicera have the effectiveness of immunomodulation, antibacterial and antiviral, which can be taken as traditional Chinese herbs by decoction or com bined with novel biotechnology to treat cancer. As a kind of malignant tumor, digestive system tumors have complex causes, multiple pathologic types, wide range of invasion, and they are often accompanied by high cost of treatment and intolerable pain. As an economical and easily accepted form of cancer treatment, herbal medicine can be used as an adjunct to surgery, radiotherapy and chemotherapy to reduce the toxic side effects and pain of these routine treatments, thus improving the quality of life and even promoting the recovery of patients. This report reviewed the main bioactive components of Lonicera and their mechanism in cancer therapy, taking hepatocellular carcinoma, colon cancer and other cancers as examples. Even though a series of achievements have been made, as of now, experiments on honeysuckle in tumor therapy are still mostly focused on the cellular and animal levels, and more clinical trials are needed in the future to elucidate its specific mechanism of action through network pharmacology and molecular docking methods, so as to better assist in the treatment of cancer.

Downloads

Download data is not yet available.

References

Ge, L., et al., Genus Lonicera: New drug discovery from traditional usage to modern chemical and pharmacological research. Phytomedicine, 2022. 96: p. 153889.

Lai, K.-H., et al., Lonicerae japonicae flos attenuates neutrophilic inflammation by inhibiting oxidative stress. Antioxidants, 2022. 11 (9): p. 1781.

Wu, S., et al., Inhibitory effects of blue honeysuckle (Lonicera caerulea L) on adjuvant-induced arthritis in rats: Crosstalk of anti-inflammatory and antioxidant effects. Journal of Functional Foods, 2015. 17: p. 514 - 523.

Li, C., et al., Lonicera rupicola Hook. f. et Thoms flavonoids ameliorated dysregulated inflammatory responses, intestinal barrier, and gut microbiome in ulcerative colitis via PI3K/AKT pathway. Phytomedicine, 2022. 104: p. 154284.

Rossi, J.-F., et al., Dynamic immune/inflammation precision medicine: the good and the bad inflammation in infection and cancer. Frontiers in immunology, 2021. 12: p. 595722.

Wan, H., et al., Effects of a novel biflavonoid of Lonicera japonica flower buds on modulating apoptosis under different oxidative conditions in hepatoma cells. Phytomedicine, 2019. 57: p. 282 - 291.

Chang, Y., et al., The metabolic profile elucidation of Lonicera japonica flos water extract and the metabolic characteristics evaluation of bioactive compounds in human gastrointestinal tract in vitro. Journal of Pharmaceutical and Biomedical Analysis, 2022. 219: p. 114906.

Geranpayehvaghei, M., et al., Cancer‐associated‐platelet‐inspired nanomedicines for cancer therapy. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2021. 13 (5): p. e1702.

Rajivgandhi, G.N., et al., Synthesis of silver nanoparticle (Ag NPs) using phytochemical rich medicinal plant Lonicera japonica for improve the cytotoxicity effect in cancer cells. Journal of King Saud University-Science, 2022. 34 (2): p. 101798.

Firdhouse, M.J. and P. Lalitha, Biogenic green synthesis of gold nanoparticles and their applications–a review of promising properties. Inorganic Chemistry Communications, 2022: p. 109800.

Liang, J., X. Huang, and G. Ma, Antimicrobial activities and mechanisms of extract and components of herbs in East Asia. RSC advances, 2022. 12 (45): p. 29197 - 29213.

Minami, M. and T. Makino Effects of Lonicera japonica Flower Bud Extract on Citrobacter rodentium-Induced Digestive Tract Infection. Medicines, 2020. 7, DOI: 10.3390/medicines7090052.

Rommasi, F., Bacterial-based methods for cancer treatment: What we know and where we are. Oncology and Therapy, 2022. 10 (1): p. 23 - 54.

1Chi, Y., et al., Inhibitory effect of Lonicera japonica-derived exosomal miR2911 on human papilloma virus. Journal of Ethnopharmacology, 2024. 318: p. 116969.

Yeh, Y.C., et al., Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) suppress SARS-CoV-2 entry and COVID-19 related cytokine storm in vitro. Frontiers in Pharmacology, 2022. 12: p. 765553.

Liu, C., et al., Honeysuckle-derived microRNA2911 inhibits tumor growth by targeting TGF-β1. Chinese Medicine, 2021. 16: p. 1 - 9.

Zhou, L., et al., Anti-tumor properties of anthocyanins from Lonicera caerulea ‘Beilei’fruit on human hepatocellular carcinoma: In vitro and in vivo study. Biomedicine & pharmacotherapy, 2018. 104: p. 520 - 529.

Ge, L., et al., Chemical constituents from Lonicera japonica flower buds and their anti-hepatoma and anti-HBV activities. Bioorganic Chemistry, 2019. 92: p. 103198.

Li, Y., et al., Effects of a chlorogenic acid-containing herbal medicine (LASNB) on colon cancer. Evidence-Based Complementary and Alternative Medicine, 2021. 2021.

Lin, L., et al., Structural elucidation of a pectin from flowers of Lonicera japonica and its ant pancreatic cancer activity. International Journal of Biological Macromolecules, 2016. 88: p. 130 - 137.

Downloads

Published

29-12-2023